Related Experiment Video
Updated: Sep 28, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
Published on: September 20, 2024
Correlation between HHV-6 reactivation and multiple sclerosis disease activity
Svetlana Chapenko1, Andrejs Millers, Zaiga Nora
1August Kirchenstein Institute of Microbiology and Virology, University of Latvia, Riga, Latvia. modra@latnet.lv
Abstract:
This study examined the association between HHV-6 infection and multiple sclerosis (MS) and the relationship between HHV-6 reactivation and disease activity. The frequency of HHV-6 genomic sequences in peripheral blood mononuclear cells (PBMCs), the incidence of plasma viremia (nPCR), the transcription of viral mRNA in PBMCs (RT-PCR), the presence of antiviral IgM and IgG class antibodies in the plasma (IFA) of 16 relapsing/remitting and secondary progressive MS patients were studied in comparison with clinical manifestations of the disease, magnetic resonance imaging (MRI) of brain, and serum interleukin (IL)-12 concentrations (ELISA). The prevalence of HHV-6 infection was significantly higher in patients with MS (16/26) than in patients with other neurological diseases (6/21) and in blood donors (43/150). HHV-6 reactivation was found during periods of disease activity with Gadolinium-enhancing lesions on MRI in both relapsing/remitting and secondary progressive MS (10/13; 76.9%). In patients with active MS disease, serum concentrations of IL-12 were significantly higher in those patients with active HHV-6 infection than in patients with latent infection. The data confirm an association between HHV-6 infection and MS and show a correlation between HHV-6 reactivation and disease activity in relapsing/remitting and secondary progressive MS. The risk of an exacerbation of MS was significantly higher (P < 0.005) in patients with active HHV-6 infection than in patients with latent infection. A clear correlation between HHV-6 reactivation and serum IL-12 concentrations during disease activity has been demonstrated. The results suggest that HHV-6 reactivation is implicated in exacerbation of MS, possibly through modulation of IL-12 synthesis.
Insights
Human herpesvirus 6 (HHV-6) infection is linked to multiple sclerosis (MS). HHV-6 reactivation correlates with MS disease activity and exacerbations, potentially via IL-12 modulation.
Area of Science:
- Virology
- Neuroimmunology
- Infectious Diseases
Background:
- Multiple Sclerosis (MS) is a chronic neurological disorder with complex etiology.
- Human Herpesvirus 6 (HHV-6) is a common virus with potential immunomodulatory effects.
Purpose of the Study:
- To investigate the association between HHV-6 infection and MS.
- To explore the relationship between HHV-6 reactivation and MS disease activity.
Main Methods:
- Assessed HHV-6 genomic sequences, plasma viremia (nPCR), viral mRNA (RT-PCR), and antiviral antibodies (IFA) in MS patients.
- Correlated viral findings with clinical disease activity, brain MRI, and serum IL-12 levels (ELISA).
Main Results:
- Significantly higher prevalence of HHV-6 infection in MS patients compared to controls.
- HHV-6 reactivation detected during active MS disease, associated with MRI-confirmed lesions.
- Elevated serum IL-12 concentrations in MS patients with active HHV-6 infection.
Conclusions:
- HHV-6 infection is associated with MS.
- HHV-6 reactivation correlates with and may drive MS disease activity and exacerbations.
- HHV-6 reactivation might contribute to MS pathogenesis through IL-12 pathway modulation.
Related Concept Videos
Multiple Sclerosis l: Introduction
Herpes
Cytomegalovirus Disease
Genital Herpes

